CFR 21-820.30d - Design Output

From knowledgebase
Revision as of 07:18, 25 August 2020 by Dirkjan (talk | contribs) (Created page with "Each manufacturer shall establish and maintain procedures for defining and documenting design output in terms that allow an adequate evaluation of conformance to design input...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Each manufacturer shall establish and maintain procedures for defining and documenting design output in terms that allow an adequate evaluation of conformance to design input requirements. Design Output procedures shall contain or make reference to acceptance criteria and shall ensure that those design outputs that are essential for the proper functioning of the device are identified. Design output shall be documented, reviewed, and approved before release. The approval, including the date and signature of the individual(s) approving the output, shall be documented.

Attention points

  • Design output control must ensure that each describes initial through final design output is documented, reviewed ad approved by approproate management.
  • The FDA expects that the more complex the process is, the more documentation is associated with control of the process.
  • Items that must be documented are:
    • Output documents for all new design or development activities
    • Modifications to a new or existing regulated product
    • The intented use of each device, including user and patient needs

The output team is usually tasked to do the following:

Mechanisms to document control over output specifications might include the following: